The Neuropathic Pain Market is expected to register a CAGR of 9.74% from 2025 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031.
The Neuropathic Pain Market report is segmented by drug type into Tricyclic anti-depressants, Local Anesthesia, Anticonvulsants, Opioids, Steroids, and Others. The sales channel segment includes Retail Pharmacies, Drug Stores, and Online Pharmacies. The market evaluation is presented in US$ for the above segmental analysis. The global analysis is broken down at the regional level and major countries.
Purpose of the ReportThe report Neuropathic Pain Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Neuropathic Pain Market Segmentation
Drug Type- Tricyclic Anti-Depressant
- Local Anasethesia
- Anticonvulsant
- Opioids
- Steriods
- Other
- Retail Pharmacies
- Drug Store
- Online Pharmacies
Strategic Insights
Neuropathic Pain Market Growth Drivers- Increasing Prevalence of Chronic Diseases: The neuropathic pain market is driven by the rising prevalence of chronic diseases like diabetes, cancer, and HIV/AIDS, which often damage nerves and trigger neuropathic pain.
- Age-Related Neuropathies and Geriatric Population: Age-related neuropathies and the higher vulnerability of the geriatric population contribute to the high demand for neuropathic pain treatments in this market segment.
- Pharmaceutical Research and Increased Accessibility: Continuous advancements in pharmaceutical research, including new therapies and drug delivery technologies, along with increasing healthcare expenses and accessibility, are driving growth in the market.
- Advances in Drug Discovery and Personalized Medicine: Advances in drug discovery and development will lead to novel therapies with improved efficacy and safety profiles, while personalized medicine approaches are gaining traction in tailoring treatments to individual patient needs.
- Digital Health Technologies and Patient Empowerment: New wave digital health technologies, such as wearables and apps, will empower patients through symptom monitoring and self-management, offering more control over their condition.
- Non-Pharmacological Interventions and Quality of Life: Non-pharmacological interventions like physiotherapy, acupuncture, and mindfulness-based therapies will complement pharmaceutical management approaches, potentially enhancing the quality of life for neuropathic pain patients.
- Growing Unmet Need and Rising Chronic Diseases: The increasing prevalence of chronic diseases and the unmet need for safe and effective pain management solutions present significant growth opportunities, including the development of novel drug formulations, targeted delivery systems, and combination therapies.
- Non-Pharmacological Interventions: There is a growing demand for non-pharmacological interventions such as physical therapy, acupuncture, and mindfulness-based techniques, complementing pharmaceutical treatments.
- Strategic Partnerships and Investment in Research: Strategic partnerships, investment in research and development, and patient education present key opportunities for companies to make a significant impact in the lives of neuropathic pain patients.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Neuropathic Pain Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Neuropathic Pain Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
REGIONAL FRAMEWORK
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The leading players of the market are: Johnson and Johnson, Pfizer, Inc., Sanofi S.A., CODA Biotherapeutics, Inc., GlaxoSmithKline PLC, Biogen Idec., Eliy Lily and Company, Bristol-Myers Sqibb, Baxter Healthcare Corporation, Neuroheal Biomedicals
The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.
Some of the customization options available based on request are additional 3–5 company profiles and country-specific analysis of 3–5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.
In the future, the neuropathic pain market will be characterized by several key trends. Innovations in drug discovery and development are resulting in new therapies that have better efficacy and safety profiles. Personalized medicine approaches, tailored to the needs of each patient, are gaining increased importance. Digital health technologies, wearables, and mobile applications are empowering patients to monitor the symptoms and engage in self-management. There is also much more focus on nonpharmacological interventions, such as physical therapy, acupuncture, or mindfulness-based techniques. Those trends together may bring significant progress in the quality of life of people suffering from neuropathic pain.
Neuropathic Pain Market is expected to grow at a CAGR of 9.74% between 2023-2031
Several factors drive the neuropathic pain market, among them being the increasing prevalence of chronic diseases such as diabetes, cancer, and HIV/AIDS, which often lead to nerve damage and neuropathic pain. The aging population is also susceptible to age-related neuropathies, further fueling market growth. Advances in pharmaceutical research and development, leading to novel therapies and drug delivery systems, are also expected to drive market expansion. The growing awareness about neuropathic pain and its management, along with the increasing advocacy of patients, also has a positive impact on the market.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Neuropathic Pain Market - By Drug Type
1.3.2 Neuropathic Pain Market - By Sales Channel
1.3.3 Neuropathic Pain Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. NEUROPATHIC PAIN MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. NEUROPATHIC PAIN MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. NEUROPATHIC PAIN MARKET - GLOBAL MARKET ANALYSIS
6.1. NEUROPATHIC PAIN - GLOBAL MARKET OVERVIEW
6.2. NEUROPATHIC PAIN - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. NEUROPATHIC PAIN MARKET - REVENUE AND FORECASTS TO 2028 - DRUG TYPE
7.1. OVERVIEW
7.2. DRUG TYPE MARKET FORECASTS AND ANALYSIS
7.3. TRICYCLIC ANTI-DEPRESSANT
7.3.1. Overview
7.3.2. Tricyclic Anti-Depressant Market Forecast and Analysis
7.4. LOCAL ANASETHESIA
7.4.1. Overview
7.4.2. Local Anasethesia Market Forecast and Analysis
7.5. ANTICONVULSANT
7.5.1. Overview
7.5.2. Anticonvulsant Market Forecast and Analysis
7.6. OPIOIDS
7.6.1. Overview
7.6.2. Opioids Market Forecast and Analysis
7.7. STERIODS
7.7.1. Overview
7.7.2. Steriods Market Forecast and Analysis
7.8. OTHER
7.8.1. Overview
7.8.2. Other Market Forecast and Analysis
8. NEUROPATHIC PAIN MARKET - REVENUE AND FORECASTS TO 2028 - SALES CHANNEL
8.1. OVERVIEW
8.2. SALES CHANNEL MARKET FORECASTS AND ANALYSIS
8.3. RETAIL PHARMACIES
8.3.1. Overview
8.3.2. Retail Pharmacies Market Forecast and Analysis
8.4. DRUG STORE
8.4.1. Overview
8.4.2. Drug Store Market Forecast and Analysis
8.5. ONLINE PHARMACIES
8.5.1. Overview
8.5.2. Online Pharmacies Market Forecast and Analysis
9. NEUROPATHIC PAIN MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Neuropathic Pain Market Overview
9.1.2 North America Neuropathic Pain Market Forecasts and Analysis
9.1.3 North America Neuropathic Pain Market Forecasts and Analysis - By Drug Type
9.1.4 North America Neuropathic Pain Market Forecasts and Analysis - By Sales Channel
9.1.5 North America Neuropathic Pain Market Forecasts and Analysis - By Countries
9.1.5.1 United States Neuropathic Pain Market
9.1.5.1.1 United States Neuropathic Pain Market by Drug Type
9.1.5.1.2 United States Neuropathic Pain Market by Sales Channel
9.1.5.2 Canada Neuropathic Pain Market
9.1.5.2.1 Canada Neuropathic Pain Market by Drug Type
9.1.5.2.2 Canada Neuropathic Pain Market by Sales Channel
9.1.5.3 Mexico Neuropathic Pain Market
9.1.5.3.1 Mexico Neuropathic Pain Market by Drug Type
9.1.5.3.2 Mexico Neuropathic Pain Market by Sales Channel
9.2. EUROPE
9.2.1 Europe Neuropathic Pain Market Overview
9.2.2 Europe Neuropathic Pain Market Forecasts and Analysis
9.2.3 Europe Neuropathic Pain Market Forecasts and Analysis - By Drug Type
9.2.4 Europe Neuropathic Pain Market Forecasts and Analysis - By Sales Channel
9.2.5 Europe Neuropathic Pain Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Neuropathic Pain Market
9.2.5.1.1 Germany Neuropathic Pain Market by Drug Type
9.2.5.1.2 Germany Neuropathic Pain Market by Sales Channel
9.2.5.2 France Neuropathic Pain Market
9.2.5.2.1 France Neuropathic Pain Market by Drug Type
9.2.5.2.2 France Neuropathic Pain Market by Sales Channel
9.2.5.3 Italy Neuropathic Pain Market
9.2.5.3.1 Italy Neuropathic Pain Market by Drug Type
9.2.5.3.2 Italy Neuropathic Pain Market by Sales Channel
9.2.5.4 Spain Neuropathic Pain Market
9.2.5.4.1 Spain Neuropathic Pain Market by Drug Type
9.2.5.4.2 Spain Neuropathic Pain Market by Sales Channel
9.2.5.5 United Kingdom Neuropathic Pain Market
9.2.5.5.1 United Kingdom Neuropathic Pain Market by Drug Type
9.2.5.5.2 United Kingdom Neuropathic Pain Market by Sales Channel
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Neuropathic Pain Market Overview
9.3.2 Asia-Pacific Neuropathic Pain Market Forecasts and Analysis
9.3.3 Asia-Pacific Neuropathic Pain Market Forecasts and Analysis - By Drug Type
9.3.4 Asia-Pacific Neuropathic Pain Market Forecasts and Analysis - By Sales Channel
9.3.5 Asia-Pacific Neuropathic Pain Market Forecasts and Analysis - By Countries
9.3.5.1 China Neuropathic Pain Market
9.3.5.1.1 China Neuropathic Pain Market by Drug Type
9.3.5.1.2 China Neuropathic Pain Market by Sales Channel
9.3.5.2 India Neuropathic Pain Market
9.3.5.2.1 India Neuropathic Pain Market by Drug Type
9.3.5.2.2 India Neuropathic Pain Market by Sales Channel
9.3.5.3 Japan Neuropathic Pain Market
9.3.5.3.1 Japan Neuropathic Pain Market by Drug Type
9.3.5.3.2 Japan Neuropathic Pain Market by Sales Channel
9.3.5.4 South Korea Neuropathic Pain Market
9.3.5.4.1 South Korea Neuropathic Pain Market by Drug Type
9.3.5.4.2 South Korea Neuropathic Pain Market by Sales Channel
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Neuropathic Pain Market Overview
9.4.2 Middle East and Africa Neuropathic Pain Market Forecasts and Analysis
9.4.3 Middle East and Africa Neuropathic Pain Market Forecasts and Analysis - By Drug Type
9.4.4 Middle East and Africa Neuropathic Pain Market Forecasts and Analysis - By Sales Channel
9.4.5 Middle East and Africa Neuropathic Pain Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Neuropathic Pain Market
9.4.5.1.1 South Africa Neuropathic Pain Market by Drug Type
9.4.5.1.2 South Africa Neuropathic Pain Market by Sales Channel
9.4.5.2 Saudi Arabia Neuropathic Pain Market
9.4.5.2.1 Saudi Arabia Neuropathic Pain Market by Drug Type
9.4.5.2.2 Saudi Arabia Neuropathic Pain Market by Sales Channel
9.4.5.3 U.A.E Neuropathic Pain Market
9.4.5.3.1 U.A.E Neuropathic Pain Market by Drug Type
9.4.5.3.2 U.A.E Neuropathic Pain Market by Sales Channel
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Neuropathic Pain Market Overview
9.5.2 South and Central America Neuropathic Pain Market Forecasts and Analysis
9.5.3 South and Central America Neuropathic Pain Market Forecasts and Analysis - By Drug Type
9.5.4 South and Central America Neuropathic Pain Market Forecasts and Analysis - By Sales Channel
9.5.5 South and Central America Neuropathic Pain Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Neuropathic Pain Market
9.5.5.1.1 Brazil Neuropathic Pain Market by Drug Type
9.5.5.1.2 Brazil Neuropathic Pain Market by Sales Channel
9.5.5.2 Argentina Neuropathic Pain Market
9.5.5.2.1 Argentina Neuropathic Pain Market by Drug Type
9.5.5.2.2 Argentina Neuropathic Pain Market by Sales Channel
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL NEUROPATHIC PAIN MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Rest of the World
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. NEUROPATHIC PAIN MARKET, KEY COMPANY PROFILES
12.1. JOHNSON AND JOHNSON SERVICES, INC.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. PFIZER, INC.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. SANOFI S.A.
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. CODA BIOTHERAPEUTICS, INC.
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. GLAXOSMITHKLINE PLC
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. BIOGEN IDEC.
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. ELIY LILY AND COMPANY
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. BRISTOL-MYERS SQIBB
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. BAXTER HEALTHCARE CORPORATION
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. NEUROHEAL BIOMEDICALS, S.L.
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
1. Johnson and Johnson
2. Pfizer, Inc.
3. Sanofi S.A.
4. CODA Biotherapeutics, Inc.
5. GlaxoSmithKline PLC
6. Biogen Idec.
7. Eliy Lily and Company
8. Bristol-Myers Sqibb
9. Baxter Healthcare Corporation
10. Neuroheal Biomedicals
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For